Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17899091 | 0.88 | NPSR1 (0.38) | ALDH1A1NPSR1MAPTMEN1KMT2A | |
| SCHEMBL17899103 | 0.87 | ALDH1A1 (0.48) | ALDH1A1NPSR1LMNA | |
| SCHEMBL17899090 | 0.85 | MEN1 (0.35) | ALDH1A1NPSR1MAPTMEN1KMT2A | |
| SCHEMBL6357099 | 0.85 | ALDH1A1 (0.47) | ALDH1A1NPSR1MAPTMEN1KMT2A | |
| SCHEMBL17899089 | 0.83 | ALDH1A1 (0.34) | ALDH1A1NPSR1MAPTMEN1KMT2A | |
| SCHEMBL17899099 | 0.83 | MEN1 (0.34) | ALDH1A1NPSR1MAPTMEN1KMT2A | |
| SCHEMBL18031822 | 0.83 | PRKCA (0.48) | ALDH1A1NPSR1MAPTMEN1KMT2A | |
| SCHEMBL17281550 | 0.83 | ALDH1A1 (0.47) | ALDH1A1NPSR1MAPTMEN1KMT2A | |
| SCHEMBL2601744 | 0.83 | ALDH1A1 (0.47) | ALDH1A1NPSR1MAPTMEN1KMT2A | |
| SCHEMBL17902874 | 0.82 | ALDH1A1 (0.40) | ALDH1A1NPSR1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9575408-B2 | Photoresist composition and method for producing photoresist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20160195809-A1 | PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160195809-A1 | PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | RER1, LCP1, COL1A1 | ALDH1A1 914/4885NPSR1 1042/4885MAPT 286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.